Porsteinsson, A.
346  results:
Search for persons X
?
2

P105: Measuring clinically relevant change in apathy sympto..:

Tuma, S ; Herrmann, N ; Perin, J...
International Psychogeriatrics.  35 (2023)  S1 - p. 126-127 , 2023
 
?
3

P104: Heterogeneity of Response to methylphenidate in apath..:

Lanctôt, KL ; Rivet, L ; Tumati, S...
International Psychogeriatrics.  35 (2023)  S1 - p. 125-126 , 2023
 
?
4

IDENTIFYING BETTER OUTCOME MEASURES TO IMPROVE TREATMENT OF..:

Sano, M. ; Soto, M. ; Carrillo, M....
The Journal Of Prevention of Alzheimer's Disease.  , 2018
 
?
7

Responders to ELND005 (Scyllo-Inositol) Demonstrate Clinica..:

Porsteinsson, A. ; Sperling, R. ; Salloway, S....
Neurology.  78 (2012)  Meeting Abstracts 1 - p. P04.194-P04.194 , 2012
 
?
8

Responder Analyses from a 78-Week Phase 2 Placebo-Controlle..:

Salloway, S. ; Sperling, R. ; Porsteinsson, A....
Neurology.  78 (2012)  Meeting Abstracts 1 - p. P04.195-P04.195 , 2012
 
?
10

Cost Consequence Analysis of ADMET 2:

Mah, Ethan ; Lanctôt, Krista ; Chen, Qi Zhen...
The American Journal of Geriatric Psychiatry.  31 (2023)  3 - p. S101 , 2023
 
1-15